Skip to main content
Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. — Investor Relations & Filings

Ticker · 688108 ISIN · CNE100003NY2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2026-03-25 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688108

About Sino Medical Sciences Technology Inc.

https://www.sinomed.com/

Sino Medical Sciences Technology Inc. (SINOMED) specializes in the research, development, and manufacturing of high-end interventional medical devices. The company focuses on cardiovascular, neurovascular, and structural heart disease treatments. Its core product portfolio includes drug-eluting stents (DES) and balloon catheters, notably the BuMA and BuMA Supreme series. SINOMED utilizes proprietary technologies, such as the eG™ coating, to improve clinical outcomes and patient safety. The company maintains a strong commitment to clinical research and international expansion, aiming to provide innovative solutions for minimally invasive procedures.

Recent filings

Filing Released Lang Actions
关于提请赛诺医疗科学技术股份有限公司股东会授权公司董事会以简易程序向特定对象发行人民币普通股（A股）股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's proposal to authorize its board to issue new shares via a simplified procedure to specific investors. It details the terms, conditions, pricing, quantity, and regulatory compliance related to this share issuance. The document is not a financial report but a formal announcement of a capital raising activity involving issuance of new shares. It does not contain financial statements or earnings data but focuses on the capital issuance process and authorization. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3172 characters, which is consistent with an announcement rather than a full report.
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司董事会关于2025年度独立董事独立性自查情况的专项报告
Governance Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of independent directors for the year 2025. It references compliance with regulatory guidelines on independent directors and confirms their qualifications and independence. The content focuses on governance and board oversight matters rather than financial results or management changes. It is not an announcement of a meeting, voting results, or a financial report. The document fits best under Governance Information (CGR) as it details the company's governance practices related to independent directors' independence.
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司关于向金融机构申请授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company about applying for a credit facility (授信额度) from a financial institution. It details the amount, purpose, and terms of the credit line, and mentions board approval. There is no financial statement, earnings data, or detailed financial analysis. The document is a financing update regarding capital structure and funding activities. It is not a full financial report, audit, or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and contains substantive content about financing, so it is not a mere announcement of a report (RPA) or a regulatory filing (RNS).
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司2025年度独立董事述职报告（马元驹）
Board/Management Information Classification · 95% confidence The document is a detailed report by an independent director of a company for the year 2025. It includes the director's background, attendance at board and committee meetings, exercise of duties, communication with shareholders, oversight of financial reporting and internal controls, and evaluation of governance matters. The content focuses on the independent director's duties, oversight, and opinions on company governance and financial matters, rather than being a full annual report or financial statement. This type of document aligns with a Management Report or a report on Board/Management Information, specifically related to independent director duties and governance oversight. It is not an announcement, certification, or a transcript of a call, nor is it a financial report or audit report. Therefore, the best fitting category is Board/Management Information (MANG).
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司未来三年（2026年-2028年）股东分红回报规划
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement from the company's board regarding the shareholder dividend return plan for the next three years (2026-2028). It outlines principles, conditions, procedures, and policies related to profit distribution and dividends. It is not a full financial report, earnings release, or regulatory certification. The document is relatively short (4110 characters) and focuses on dividend policy planning rather than actual dividend amounts or payment notices. Therefore, it is best classified as a Notice of Dividend Amount (DIV) type, as it relates to dividend planning and shareholder returns over a defined period.
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司关于2025年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2025 profit distribution plan, including details on no cash dividends, reasons for the decision, and approvals by the board and committees. It contains no full financial statements or comprehensive financial performance data typical of an Annual Report or Interim Report. It is a formal announcement about dividend policy and profit distribution, which fits the category of Notice of Dividend Amount (DIV). The document length is about 4993 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is DIV with high confidence.
2026-03-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.